New to Meducation?
Already signed up?
Add To Boards
New antibody therapy dramatically improves psoriasis symptoms in clinical trial
Only a single treatment produced what researchers describe as 'rapid, substantial, and durable clinical...
Help by adding tags...
Cosentyx (secukinumab) is the first IL-17A inhibitor to be available for moderate to severe plaque psoriasis in the UK
- Novartis Pharmaceuticals UK Limited (Novartis) has announced that Cosentyx (secukinumab) is available for use in the UK for the treatment of moderate to severe plaque psoriasis in adults who...
- Classifications of antibiotics - a useful summary. The Table is no way complete. Kindly Ignore Spelling mistakes Checkout mynotes4usmle.tumblr.com for more
Provectus Biopharmaceuticals begins recruitment for phase 2 mechanism of action clinical trial of PH-10 for psoriasis
- Provectus Biopharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company ('Provectus'), has announced that it has opened recruitment for its phase 2 mechanism...
Psoriasis: Otezla (apremilast), receives European marketing authorisation in two therapeutic indications
- Celgene UK has announced that the European Commission has licensed Otezla, the Company's oral selective inhibitor of phosphodiesterase 4 (PDE4), in two therapeutic...
Clinical trial results of potential migraine therapy to be presented by Achelios Therapeutics
- TOPOFEN (TM) is a new and novel topical medication for the treatment of acute migraineAchelios Therapeutics will announce results from a Phase IIa placebo-controlled...
FDA OKs Topical Drug Combo (Enstilar) for Plaque Psoriasis
- Enstilar combines calcipotriene and betamethasone dipropionate in a foam formulation for topical treatment of plaque psoriasis in adults.
Acute back pain Presentation
- An overview of clinical back pain, looking at common aetiology and methods of avoiding reinjury.